Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.4K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Quality Assurance01:19

Quality Assurance

1.1K
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
1.1K
Data Reporting and Recording01:24

Data Reporting and Recording

5.4K
Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.4K
Nursing Clinical Information System01:27

Nursing Clinical Information System

1.3K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Additional Ethical Tension in Personal Utility in Genomic Testing: System Restrictions vs. Patient Safety.

The American journal of bioethics : AJOB·2026
Same author

Perspectives on Ethical Issues in Neurotechnology Industry-Academia Partnerships: Voices of Industry (Neuro)Ethicists.

AJOB neuroscience·2026
Same author

Enhancing Data Quality in Clinical Trials: Cross-Company Validation of the Open-Source Clinical Trial Anomaly Spotter (CTAS).

Therapeutic innovation & regulatory science·2026
Same author

Beyond Ethics-Based Initiatives for Mitigating Bias in Machine Learning Models: An Integrated Ethics by Design Framework.

The American journal of bioethics : AJOB·2026
Same author

Clearing the Mist: The Distinct Roles of Transparency and Explainability for Using AI in Drug and Device Development.

Pharmaceutical medicine·2025
Same author

Breaching Confidentiality in Genetic and Non-Genetic Cases: Two Problematic Distinctions - When the Law Comes to the Rescue.

The American journal of bioethics : AJOB·2025

Related Experiment Video

Updated: Jan 24, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K

Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine

Timothé Ménard1, Yves Barmaz2, Björn Koneswarakantha2

  • 1F. Hoffmann-La Roche, Basel, Switzerland. timothemenard@gmail.com.

Drug Safety
|May 25, 2019
PubMed
Summary

This study developed a machine learning model to automatically detect adverse event (AE) under-reporting in clinical trials, improving patient safety and data integrity. The model achieved high accuracy in simulations, aiding Quality Assurance (QA) processes.

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.7K

Related Experiment Videos

Last Updated: Jan 24, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.7K

Area of Science:

  • Clinical Quality Assurance
  • Data Science in Pharmaceuticals
  • Machine Learning in Healthcare

Background:

  • Adverse event (AE) under-reporting is a persistent issue in clinical trials, compromising patient safety and data integrity.
  • Traditional Quality Assurance (QA) methods, like audits, have limitations in detecting AE under-reporting, leading to regulatory submission delays.
  • Advancements in data management and IT enable automated detection of AE under-reporting using machine learning.

Purpose of the Study:

  • To develop a predictive machine learning model for proactive oversight of AE reporting at various levels (program, study, site, patient).
  • To augment traditional clinical QA approaches with advanced analytics for enhanced safety monitoring.
  • To provide Quality Program Leads with tools to identify and address potential safety reporting issues.

Main Methods:

  • A machine learning model was trained using a curated dataset of 104 completed Roche/Genentech sponsored clinical studies.
  • The model utilized 54 features, including patient demographics, vitals, molecule class, and disease area.
  • Model performance was evaluated using simulated under-reporting scenarios (25%, 50%, 75%) on site-level data.

Main Results:

  • The predictive model demonstrated strong performance in detecting simulated AE under-reporting.
  • Area Under the Curve (AUC) scores for the receiver operating characteristic (ROC) curve reached 0.62, 0.79, and 0.92 for 25%, 50%, and 75% under-reporting scenarios, respectively.
  • The model successfully identified varying degrees of under-reporting with increasing accuracy.

Conclusions:

  • The developed machine learning model has been deployed as a QA/dashboard cockpit for ongoing study safety reporting evaluation.
  • The model aims to enhance the oversight of AE reporting and complement existing QA processes.
  • Further validation and integration into Roche QA processes are planned over the next 12-24 months to assess long-term applicability and performance.